Moderna Inc’s recent filing unveils that its Chief Legal Officer Klinger Shannon Thyme unloaded Company’s shares for reported $40539.0 on Sep 09 ’24. In the deal valued at $73.57 per share,551 shares were sold. As a result of this transaction, Klinger Shannon Thyme now holds 18,154 shares worth roughly $1.07 million.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Then, Klinger Shannon Thyme bought 551 shares, generating $40,539 in total proceeds.
Before that, Klinger Shannon Thyme sold 114 shares. Moderna Inc shares valued at $8,777 were divested by the Chief Legal Officer at a price of $76.99 per share. As a result of the transaction, Klinger Shannon Thyme now holds 17,566 shares, worth roughly $1.03 million.
Oppenheimer downgraded its Moderna Inc [MRNA] rating to a Perform from a an Outperform in a research note published recently. A number of analysts have revised their coverage, including JP Morgan’s analysts, who decreased its forecast for the stock in mid September from “a Neutral” to “an Underweight”. Jefferies also remained covering MRNA and has decreased its forecast on September 13, 2024 with a “Hold” recommendation from previously “Buy” rating. HSBC Securities revised its rating on August 28, 2024. It rated MRNA as “a Hold” which previously was an “a Reduce”.
Price Performance Review of MRNA
On Monday, Moderna Inc [NASDAQ:MRNA] saw its stock fall -2.46% to $58.72. Over the last five days, the stock has lost -12.14%. Moderna Inc shares have fallen nearly -40.96% since the year began. Nevertheless, the stocks have fallen -42.97% over the past one year. While a 52-week high of $170.47 was reached on 05/24/24, a 52-week low of $59.62 was recorded on 10/07/24. SMA at 50 days reached $78.08, while 200 days put it at $104.86.
Levels Of Support And Resistance For MRNA Stock
The 24-hour chart illustrates a support level at 57.82, which if violated will result in even more drops to 56.91. On the upside, there is a resistance level at 60.14. A further resistance level may holdings at 61.55. The Relative Strength Index (RSI) on the 14-day chart is 26.27, which indicates oversold technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -4.21, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bearish at 97.40%. Stochastics %K at 2.19% indicates the stock is a buying.
How much short interest is there in Moderna Inc?
A steep rise in short interest was recorded in Moderna Inc stocks on 2024-09-13, growing by 2.61 million shares to a total of 27.61 million shares. Yahoo Finance data shows the prior-month short interest on 2024-08-15 was 25.0 million shares. There was a rise of 9.45%, which implies that there is a positive sentiment for the stock.
